In China, the National Medical Products Administration (NMPA), formerly the China Food and Drug Administration (CFDA), conducts pharmaceutical audits. The NMPA oversees drug approvals, quality control, and ensures adherence to regulations. It regularly inspects manufacturing sites, clinical trial conduct, and post-market surveillance to ensure public safety and compliance.
